Your browser doesn't support javascript.
loading
Higher disease burden and lower utilization in Mongolian with breast cancer: a 9-year retrospective cohort study of 18.19 million adults in China.
Chen, Jieying; Qiao, Liying; Qi, Meng; Zhang, Yunjing; Yan, Ying; Kang, Weiwei; Zhou, Huziwei; Yu, Yuelin; Ke, Yalei; Jiang, Yuling; Rao, Yingting; Xu, Lu; He, Guohua; Ren, Jing; Yan, Xue; Deng, Siwei; Yang, Xinyu; Song, Yutong; Yang, Yingzi; Wen, Qiaorui; Han, Jing; Wu, Yiwei; Liu, Guozhen; Wang, Mingyuan; Zhang, Xiaoyu; Xi, Yunfeng; Wang, Shengfeng.
Affiliation
  • Chen J; School of Health Humanities, Peking University.
  • Qiao L; Inner Mongolia Autonomous Region Center for Disease Control and Prevention (Inner Mongolia Autonomous Region Academy of Preventive Medicine).
  • Qi M; Breast Center, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital and Institute.
  • Zhang Y; Department of Epidemiology and Biostatistics, School of Public Health, Peking University.
  • Yan Y; Department of Breast Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital and Institute.
  • Kang W; Inner Mongolia Autonomous Region Center for Disease Control and Prevention (Inner Mongolia Autonomous Region Academy of Preventive Medicine).
  • Zhou H; Department of Epidemiology and Biostatistics, School of Public Health, Peking University.
  • Yu Y; Department of Epidemiology and Biostatistics, School of Public Health, Peking University.
  • Ke Y; Department of Epidemiology and Biostatistics, School of Public Health, Peking University.
  • Jiang Y; Department of Epidemiology and Biostatistics, School of Public Health, Peking University.
  • Rao Y; Department of Epidemiology and Biostatistics, School of Public Health, Peking University.
  • Xu L; Research Center of Clinical Epidemiology, Peking University Third Hospital.
  • He G; The First Affiliated Hospital, Sun Yat-sen University, Guangzhou.
  • Ren J; Inner Mongolia Autonomous Region Center for Disease Control and Prevention (Inner Mongolia Autonomous Region Academy of Preventive Medicine).
  • Yan X; Inner Mongolia Autonomous Region Center for Disease Control and Prevention (Inner Mongolia Autonomous Region Academy of Preventive Medicine).
  • Deng S; Department of Epidemiology and Biostatistics, School of Public Health, Peking University.
  • Yang X; School of Public Health, Peking University.
  • Song Y; School of Public Health, Peking University.
  • Yang Y; Department of Epidemiology and Biostatistics, School of Public Health, Peking University.
  • Wen Q; Department of Epidemiology and Biostatistics, School of Public Health, Peking University.
  • Han J; Inner Mongolia Autonomous Region Center for Disease Control and Prevention (Inner Mongolia Autonomous Region Academy of Preventive Medicine).
  • Wu Y; Inner Mongolia Autonomous Region Center for Disease Control and Prevention (Inner Mongolia Autonomous Region Academy of Preventive Medicine).
  • Liu G; Peking University Health Information Technology, Beijing.
  • Wang M; Peking University Health Information Technology, Beijing.
  • Zhang X; School of Public Health, Peking University.
  • Xi Y; Inner Mongolia Autonomous Region Center for Disease Control and Prevention (Inner Mongolia Autonomous Region Academy of Preventive Medicine).
  • Wang S; Department of Epidemiology and Biostatistics, School of Public Health, Peking University.
Int J Surg ; 110(8): 4588-4597, 2024 Aug 01.
Article in En | MEDLINE | ID: mdl-38608032
ABSTRACT

BACKGROUND:

Whether health inequalities of disease burden and medical utilization exist by ethnicity in Asian breast cancer (BC) patients remains unclear. The authors aim to measure ethnic disparities in disease burden and utilization among Mongolian and Han female BC patients in China. MATERIALS AND

METHODS:

Based on data extracted from Inner Mongolia Regional Health Information Platform, a retrospective cohort study was established during 2012-2021. Disease burden including incidence, 5-year prevalence, mortality, survival rate, and medical cost were analyzed and compared between Han and Mongolian patients.

RESULTS:

A total of 34 878 female patients [mean (SD) age, 52.34 (10.93) years] were included among 18.19 million Chinese, and 4315 (12.03%) participants were Mongolian. Age-standardized rates of incidence are 32.68 (95% CI 20.39-44.98) per 100 000. Higher age-specific incidence and 5-year prevalence were observed in Mongolian than in Han. The cost of BC annually per capita was significantly lower for Mongolian than Han [$1948.43 (590.11-4 776.42) vs. $2227.35 (686.65-5929.59), P <0.001]. Mongolian females showed higher all-cause mortality [30.92 (95% CI 28.15-33.89) vs. 27.78 (95% CI 26.77-28.83) per 1000, P =0.036] and BC-specific mortality [18.78 (95% CI 16.64-21.13) vs. 15.22 (95% CI 14.47-16.00) per 1000, P =0.002] than Han females. After adjusting covariates, Mongolian were associated with increased all-cause mortality [HR, 1.21, (95% CI 1.09-1.34); P <0.001] and BC-specific mortality [HR, 1.31, (95% CI 1.14-1.49); P <0.001].

CONCLUSION:

The findings of this cohort study highlight a higher level of disease burden with unmet medical demand in Mongolian patients, suggesting that more practical efforts should be made for the minority. Further research is needed to explore the concrete mechanisms of the disparities as well as eliminate health disproportion.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Cost of Illness Limits: Adult / Aged / Female / Humans / Middle aged Country/Region as subject: Asia Language: En Journal: Int J Surg Year: 2024 Document type: Article Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Cost of Illness Limits: Adult / Aged / Female / Humans / Middle aged Country/Region as subject: Asia Language: En Journal: Int J Surg Year: 2024 Document type: Article Country of publication: